-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1512.pdf
December 01, 2015 - individuals with BMIs of 27
kg/m2 or more and at least one obesity-related comorbid condition.85 The guidelines … therapy is safe and effective, defined as weight loss of 5% or greater of body weight
at 3 months, the guidelines … continuing the medication, and stopping if ineffective or
unsafe.85 Further, the Endocrine Society guidelines … American College of Cardiology/American
Heart Association Task Force on Practice
Guidelines, Obesity … Expert
panel report: guidelines (2013) for the
management of overweight and obesity in
adults.
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-fullreport.pdf
August 07, 2018 - • Ensuring guidelines will be made available for physicians regarding the risk-benefit balance
for
-
cds.ahrq.gov/sites/default/files/workgroups/33746/CDS_Connect_WG_Summary_September_2021.pdf
January 01, 2021 - Interoperability Resources (FHIR), Application Programming Interface (API), Drupal,
Clinical Practice Guidelines
-
digital.ahrq.gov/ahrq-funded-projects/integris-telewoundcare-network
January 01, 2023 - The study was a controlled trial to evaluate a telehealth strategy, which incorporated evidence-based guidelines
-
effectivehealthcare.ahrq.gov/sites/default/files/llewellyn-thomas.pdf
January 01, 2011 - o health
policy; health
economics; practice
guidelines;
o human
judgment and
decision
-
psnet.ahrq.gov/node/846935/psn-pdf
March 29, 2023 - Events Related to Perinatal Mental Health
As highlighted by the patient safety bundles and clinical guidelines
-
psnet.ahrq.gov/node/49673/psn-pdf
December 01, 2012 - ACC/AHA 2007 guidelines for the management of patients
with unstable angina/non–ST-elevation myocardial
-
meps.ahrq.gov/data_files/publications/st187/stat187.pdf
October 01, 2007 - Treatment of the High Blood Cholesterol in Adults (Adult Treatment Panel III):
http://www.nhlbi.nih.gov/guidelines
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-272-genitourinary-syndrome-disposition-comments.pdf
July 31, 2024 - excluded to focus on interventions
available to U.S. clinicians (since American Urological Association guidelines
-
psnet.ahrq.gov/web-mm/anesthesia-weighty-issue
September 01, 2006 - December 18, 2019
Use of pediatric injectable medicines guidelines and associated medication
-
psnet.ahrq.gov/node/861882/psn-pdf
January 31, 2024 - contributing to medication errors, knowledge lapses regarding special populations or
updated treatment guidelines
-
psnet.ahrq.gov/perspective/safety-retail-pharmacy
May 11, 2016 - During the adjudication process, pharmacists engage with third-party insurers' guidelines on required
-
psnet.ahrq.gov/web-mm/patient-mix
December 01, 2007 - Annual Perspective: Topics in Medication Safety
March 31, 2022
Guidelines
-
psnet.ahrq.gov/web-mm/admission-drug-dose-too-low
September 01, 2011 - the toxic range at admission.( 5 ) In this case, the admitting physician failed to follow appropriate guidelines
-
www.ahrq.gov/sites/default/files/wysiwyg/lhs/lhs_case_studies_hca.pdf
April 01, 2019 - As a result, new guidelines on catheter use were implemented
across the health system.
-
psnet.ahrq.gov/web-mm/overriding-considerations
March 09, 2009 - February 10, 2016
Evaluation of clinical practice guidelines on fall prevention and management
-
psnet.ahrq.gov/web-mm/nonsustained-ventricular-tachycardia-after-acute-coronary-syndromes-recognizing-high-risk
September 20, 2011 - Part 1: executive summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation
-
psnet.ahrq.gov/web-mm/hold-tpa
July 29, 2020 - Guidelines for the early management of patients with ischemic stroke: a scientific statement from the
-
hcup-us.ahrq.gov/datainnovations/raceethnicitytoolkit/nm2.pdf
June 01, 2011 - meaningful use” incentive payments
◦ Race/Ethnicity categories to follow Office of Management and Budget guidelines
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/masks-prevention-covid-surveillance-report.pdf
July 17, 2020 - endorsement of any derivative products that may be
developed from this report, such as clinical practice guidelines